CE-mark And Launch Of CERAMENT™|G The First Injectable Gentamicin Eluting Bone Substitute To Promote And Protect Bone Healing In Osteomyelitis

Scandinavian medtech company Bonesupport is an emerging leader in injectable bone substitutes for orthopedic trauma, bone infections and instrument augmentation related to orthopedic surgery. The company has announced that the next generation product of the CERAMENT™ family, CERAMENT™|G has received CE-mark.

FDA PMA For VASCADE™ Vascular Closure System

Cardiva Medical, Inc. has gained an FDA Premarket Approval (PMA) for the VASCADE Vascular Closure System (VCS). Clinical data demonstrated that the VASCADE VCS is clinically and statistically superior in both safety and efficacy compared to manual compression for patients undergoing percutaneous procedures through the femoral artery.

Most read

Latest

^